Genetics of Cancer Flashcards
tumor progression
normal -> hyperplastic –> dysplastic –> neoplastic (cells become immortal) –> metastatic
tumor progression results from waves of mutation followed by
clonal expansion
incidence of cancer increases exponentially with
age (5th to 6th power)
are cancers derived from a single cell
yes they are monoclonal - mutation increases with time
what strongly suggests that cancer cells are derived from a single cell
all cells from cancer have the same copy of the X inactivated
malignancy of B cell (produce antibody producing plasma cells)
multiple myeloma
all myeloma patients produce the same antibody molecule which is
monoclonal Ig (M-spike) proves monoclonality of cancer
net cell growth in a healthy individual is what
cell birth = cell death
in cancer, cell birth > cell death
what are the cancer causing genes
oncogenes (normally stimulates growth) suppressor genes (normally inhibit growth) repair genes (normally limit mutations)
types of mutations in the cancer causing genes
proto-oncogene - gain of function mutation
tumor suppressor genes - loss of function
repair genes - increase frequency of mutations
MAP kinase pathway - cellular growth control
- growth factors
- growth factor receptor tyrosine kinase
- cytoplasmic receptor tyrosine kinase
- proteins with GTPase activity/cytosolic signal transducer
- DNA binding nuclear protein transcription factors
for cellular growth control, where do the instructions come from
outside of the cell (growth factors)
1 and 2 are extracellular
3 and 4 are cytoplasmic
5 on nucleus
regulates cell proliferation
proto-oncogenes <— mutation in it leads to oncogene
what happens when mutation of proto-oncogene
production of mutant protein that results that stimulates cell division or increased expression of a gene that leads to large amount of protein which stimulates cell division
how does MAP kinase cascade amplify signals
through geometric recruitment
what happens with the activation of kinases
phosphorylation of serine and threonine residues
how is tyrosine kinase receptor/growth receptor activated
ligand aka growth factors bind to the receptors which then dimerize and phosphorylate then there is further phosphorylation of tyrosine residues
how do you oncogenically activate a receptor
point mutation on the receptor (Val –>Gln) which changes a single amino acid making receptor constitutively active (Neu oncoprotein)
truncation/deletion - in absence of signal, receptors still dimerize and become constitutively active (ErbB oncoprotein)
oncogenic activation by translation aka illegitimate recombination
Burkitt lymphoma (activation of myc) chronic myeloid leukemia (activation of abl)
what is myc
nuclear transcription factor (5) that is impo for G1/S transition and stimulates the cell cycle
mechanism in Burkitt lymphoma
recombination between chromosome 8 and 14 which puts myc (8) under the control of IgH promoter (14) now causing increased production of myc (usually made in small amounts) which leads to overstimulation of the cell cycle —> cancer
what fails to differentiate in Burkitt lymphoma
lymphocytes
another name for chronic myeloid leukemia
philadelphia chromosome 22
mechanism in chronic myeloid leukemia
recombination between chromosome 9 and 22 which makes a hybrid with abl (9) and bcr (22) genes fused together —> unregulated cystolic tyrosine kinase so abl is stuck in its active form not needing a signal to activate
what is abl
a cytoplasmic tyrosine kinase (3)
what can be used to block the bcr-abl hybrid
gleevec or imatinib mesylate (STI571)
mechanism of imatinib mesylate
it is a tyrosine kinase inhibitor so it binds to the bcr-abl hybrid active site and prevents its activity
A 52 year-old man with chronic myelogenous leukemia tests positive for the presence of the Philadelphia chromosome. How does this change the ABL proto- oncogene to an oncogene? This protein
constitutive kinase activity
what is Ras (4)
GTPase involved in major cell proliferative pathway
how does Ras work
when GDP phosphorylated to GTP and binds to Ras, it is active but once it binds to GDP, it becomes inactive so it needs constant stimulation to grow
how does Ras become constitutively active
when a mutation occurs that inhibits GTPase activity so Ras stays bound to GTP hence there is growth
mutation - single point mutants at Gly12 or Gln61
what is usually seen with FISH probes in tumors where amplified region includes an oncogene
double minutes - extrachromosomal fragments of DNA
Abnormal Homogeneously Staining Regions of Chromosomes in Cancers Often contain
amplified oncogenes
growth factor receptor
HER2
cytosolic signal transducer
Ras
A clinical genomicist observes dmins (double minutes) in a metaphase spread. These aberrations result due to which of the following processes?
extrachromosomal fragments of DNA/ extrachromosomal gene amplifications
A clinical genomicist observes hsrs (homogeneously staining regions) in a metaphase spread. These aberrations result due to which of the following processes
gene amplification in tandem
many inherited disposition to cancer result from mutations in
tumor suppressor genes
loss of function in the WT1 gene on chromosome 11
Wilms Tumor 11